Introduction {#s1}
============

Kidney damage usually begins as an incident of proteinuria, which is most often assessed as microalbuminuria in the clinical setting for early detection of kidney disease \[[@R01], [@R02]\]. However, in apparently healthy community dwellers, who are supposed to undergo annual checkups for managing their health, measurement of microalbuminuria is unfeasible because of its cost and it is time consuming. In an ordinary health checkup, proteinuria defined as ≥ +1 is measured using dipstick urinalysis, which is considered as unable to detect microalbuminuria \[[@R03]\].

To date, clinical significance of trace proteinuria (TrP), which is assessed as ± by dipstick urinalysis, is generally classified as normal and of limited clinical significance \[[@R03]-[@R06]\]. In spite of limited evidence, several studies have suggested that TrP usually indicates microalbuminuria \[[@R04], [@R07]\], and that a large portion of microalbuminuria (albumin/creatinine ratio (30 - 300 mg/g)) overlaps with TrP \[[@R06]\]. However, the association between TrP and overt proteinuria (OP) (≥ +1), which is an established marker of chronic kidney disease \[[@R03], [@R05]\], is unknown.

Therefore, we investigated the association between TrP detected during the initial 2 years and the incidence of OP after 5 years in a community-based cohort study. The cohort comprised 292,257 healthy people who did not have OP during the initial 2 years. Because proteinuria including TrP can transiently result from various physiological conditions \[[@R01], [@R03]\], we classified TrP into transient TrP (positive once in 2 years) (T-TrP) and recurrent TrP (positive twice in 2 years) (R-TrP). Additionally, we investigated the difference in the detection rate for TrP between visual reading (VR) by medical staff and automated reading (AR) using a machine, because this difference can affect the detection rate of TrP.

Materials and Methods {#s2}
=====================

Study design {#s2a}
------------

Our project was a composite study that consisted of secondary use of health checkup data in Japan, which is termed the Kanagawa Investigation of the Total Checkup Data from the National Database (KITCHEN). This original study aimed to determine factors associated with cardiometabolic diseases. The study design is described in detail elsewhere \[[@R08]\]. Since 2008, all people living in Japan aged 40 - 74 years are supposed to undergo a yearly specific health checkup managed by the Ministry of Health, Labour and Welfare (MHLW) \[[@R9]\]. The study protocol was approved by the Ethics Committee of Kanagawa University of Human Services (No.10-43) and MHLW in Japan (No. 121). We received digitally recorded anonymous data regarding people living in Kanagawa Prefecture from the MHLW as part of its nationwide program, which involves the provision of medical data to third parties. To protect against the identification of specific individuals, their ages were already categorized as 40 - 44, 45 - 49, 50 - 54, 55 - 59, 60 - 64, and 65 - 69 years. In this study, to evaluate subject age as a single numeric value, we transformed the age groups into substituted ages (s-age), corresponding to the median for each age group (42, 47, 52, 57, 62, and 67 years, respectively). This study was conducted in compliance with the ethical standards of the responsible institution on human subjects as well as with the Helsinki Declaration.

Subjects {#s2b}
--------

This cohort study used data of people who attended checkups three times during 6 years: April 2008 to March 2010 (initial 2 years) and April 2014 to March 2015. Participants who reported having kidney disease during the initial 2 years from April 2008 to March 2010 were excluded. Subjects with OP during the initial 2 years were also excluded. Consequently, 292,257 subjects aged 40 - 68 years with complete data (men, 58.0%) were enrolled in the study. However, individuals at moderate to severe conditions were unlikely to be involved in this study because healthcare stuff in checkup institutions advised such people to go a hospital or clinic immediately.

Measurements of clinical parameters {#s2c}
-----------------------------------

Measurements were conducted in the morning after an overnight fast. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m^2^). Clinical parameters were measured with internal and external standards, as instructed by the Ministry of Health, Labour and Welfare \[[@R9]\]. Dipstick urinalysis was conducted with VR by medical staff or by AR using a machine reader with reflectance photometry. The grade of proteinuria was classified as five grades: none (-), trace (±), +1, +2, and ≥ +3. We classified TrP into T-TrP (positive once in 2 years) and R-TrP (positive twice in 2 years). Because OP and TrP showed a J-shaped relationship against BMI in previous studies \[[@R10], [@R11]\], the relationship between two types of TrP and BMI were examined in this study.

Unfortunately, the data of estimated glomerular filtration rate (eGFR) and measurements related to urine specimens were unavailable in our database because this checkup had started for the screening of metabolic syndrome \[[@R08]\], although it is well known at present time that metabolic syndrome and cardiovascular disease are closely associated with impaired kidney function \[[@R12], [@R13]\].

Statistical analysis {#s2d}
--------------------

Data are expressed as the mean ± standard deviation (SD) or median (interquartile range). Continuous and categorical variables were analyzed by analysis of variance (ANOVA) and the χ^2^ test, respectively. A trend for T-TrP and R-TrP was tested by the Cochran-Armitage test. The Mantel-Haenszel test was used to investigate the effect of different interpretations (VR alone, VR/AR, and AR alone) of the percentages of two types of TrP. Logistic regression models were used to examine the associations between T-TrP and R-TrP and OP, with adjustment for relevant confounding factors, yielding odds ratios (ORs) and 95% confidence intervals (CIs). Confounding factors were chosen based on biological plausibility, but not with stepwise procedure. Statistical analyses were performed using SAS-Enterprise Guide (SAS-EG 7.1) in the SAS system, version 9.4 (SAS Institute, Cary, NC, USA). P \< 0.05 was considered significant.

Results {#s3}
=======

Baseline characteristics of the subjects according to TrP categories are shown in [Table 1](#T1){ref-type="table"}. The prevalence of T-TrP (8.5%) was much higher than that of R-TrP (1.3%) (P \< 0.0001, χ^2^ test). As shifted from absence of TrP to T-TrP and R-TrP, age, BMI, systolic blood pressure, serum triglyceride levels, and HbA1c levels were significantly increased, whereas serum high-density lipoprotein cholesterol levels were decreased. Simultaneously, the prevalence of men, pharmacotherapies (hypertension, diabetes, and dyslipidemia), current smokers, and daily alcohol drinkers was increased, although the prevalence of habitual exercisers was not. Half of dipstick urinalysis was interpreted with AR alone (49.8%) and 39.9% was interpreted with VR alone. The proportions of T-TrP and R-TrP were significantly higher when they were measured with AR alone compared with VR alone (Mantel-Haenszel test, P \< 0.0001). The relationship between the prevalence of T-TrP and R-TrP with BMI categories showed a J-shaped curve with the bottom of the curve at a BMI of approximately 20.0 kg/m^2^ ([Fig. 1](#F1){ref-type="fig"}). The T-TrP was higher than R-TrP, regardless of sex and BMI categories.

###### Baseline Characteristics of the Subjects According to T-TrP and R-TrP

                                                  Absence of TrP   T-TrP           R-TrP
  ----------------------------------------------- ---------------- --------------- ----------------
  N (% in total)                                  263,708 (90.2)   24,782 (8.5)    3,767 (1.3)
  Methods of detection for proteinuria                                             
    VR for both years, n (%)                      107,764 (92.4)   7,817 (6.7)     1,050 (0.9)
    VR/AR for each year, n (%)                    26,886 (89.0)    3,040 (10.1)    300 (1.0)
    AR for both years, n (%)                      129,058 (88.8)   13,925 (9.6)    2,417 (1.7)^a^
  Men, n (%)                                      152,106 (57.7)   14,836 (59.9)   2,504 (66.5)
  S-age (years)                                   53.1 ± 8.7       53.4 ± 9.1      53.8 ± 9.1
  Body mass index (kg/m^2^)                       22.8 ± 3.2       23.2 ± 3.5      23.6 ± 3.6
  Systolic blood pressure (mm Hg)                 123 ± 16.6       124 ± 17.2      125 ± 17.7
  Triglycerides (mg/dL)                           95 (67 - 140)    98 (69 - 144)   106 (72 - 155)
  High-density lipoprotein cholesterol (mg/dL)    64.3 ± 16.9      63.1 ± 17.0     61.4 ± 17.0
  HbA1c (%)                                       5.5 ± 0.6        5.6 ± 0.7       5.7 ± 0.8
  Pharmacotherapy for                                                              
    Hypertension, n (%)                           35,191 (13.3)    4,247 (17.1)    758 (20.1)
    Diabetes, n (%)                               5,579 (2.1)      792 (3.2)       165 (4.4)
    Dyslipidemia, n (%)                           21,682 (8.2)     2,284 (9.2)     383 (10.2)
  Past history of cardiovascular disease, n (%)   6,935 (2.6)      805 (3.3)       176 (4.7)
  Current smokers, n (%)                          64,389 (24.4)    6,698 (27.0)    1,155 (30.7)
  Habitual exercisers, n (%)^b^                   77,174 (29.3)    7,194 (29.0)    1,069 (28.4)
  Daily alcohol drinkers, n (%)^c^                78,399 (29.7)    7,460 (30.1)    1,214 (32.2)

Data are presented as mean ± SD, median (interquartile range), or number (%). All P values, except for exercise and alcohol drinkers, determined by ANOVA (continuous variables), and the χ^2^ and Cochran-Armitage test (categorical variables), are \< 0.0001, respectively. ^a^Methods of detection for TrP, Mantel-Haenszel test (P \< 0.0001). ^b^Exercise of sweating lightly for over 30 min per session, two times weekly, χ^2^ test, P = 0.38; Cochran-Armitage test, P = 0.18. ^c^χ^2^ test, P = 0.002; Cochran-Armitage test, P = 0.003. TrP: trace proteinuria; T-TrP: transient trace proteinuria; R-TrP: recurrent trace proteinuria; s-age: substituted age; VR: visual reading; AR: automated reading using a machine; SD: standard deviation; ANOVA: analysis of variance.

![Proportion of subjects with TrP according to BMI categories. The circle in the middle of each bar shows the mean percentage of subjects with TrP (± on dipstick urinalysis) according to BMI intervals (1.0 kg/m^2^). This percentage was calculated as the number of subjects with TrP/number of subjects in each BMI group × 100 for each BMI interval (1.0 kg/m^2^ intervals). The vertical bar represents the standard error when TrP is 1 and non-TrP is 0. ^†^BMI from 35.0 to 50.0 kg/m^2^. BMI: body mass index; TrP: trace proteinuria; T-TrP: transient TrP; R-TrP: recurrent TrP.](jocmr-12-618-g001){#F1}

[Table 2](#T2){ref-type="table"} shows the incidents of OP after 5 year according to types of TrP and the sub-groups. Overall, the incident of OP after 5 years was larger (around 10%) in R-TrP than T-TrP (around 5%): approximately two times. Subsequently, logistic regression analysis showed that T-TrP and R-TrP were significantly associated with OP after 5 years, even after adjustment for relevant confounders, including baseline BMI ([Table 2](#T2){ref-type="table"}). Associations after full adjustment were not perceivably altered when subjects were divided into three groups who had TrP interpreted with different methods (VR alone, VR/AR, and AR alone), non-obese subjects (BMI \< 25.0 kg/m^2^) and obese subjects (BMI ≥ 25.0 kg/m^2^), or men and women.

###### Odds Ratios (ORs) (95% Confidence Intervals) of T-TrP and R-TrP for the Incident of OP After Five Years

  TrP (baseline n)               Absence of TrP (263,708)   T-TrP (24,782)       R-TrP (3,767)
  ------------------------------ -------------------------- -------------------- --------------------
  Total, OP, n (%)               4,866 (1.8)                1,356 (5.5)          381 (10.1)
    Model 1                      1 (reference)              3.08 (2.90 - 3.28)   5.99 (5.36 - 6.68)
    Model 2                      1 (reference)              3.02 (2.84 - 3.21)   5.63 (5.04 - 6.28)
    Model 3                      1 (reference)              2.77 (2.60 - 2.95)   4.85 (4.34 - 5.43)
  VR alone, OP, n (%)            2,247 (2.1)                468 (6.0)            129 (12.3)
    Model 3                      1 (reference)              2.65 (2.38 - 2.94)   5.21 (4.29 - 6.33)
  VR/AR, OP, n (%)               519 (1.9)                  161 (5.3)            32 (10.7)
    Model 3                      1 (reference)              2.56 (2.13 - 3.08)   4.74 (3.22 - 6.98)
  AR alone, OP, n (%)            2,100 (1.6)                727 (5.2)            220 (9.1)
    Model 3                      1 (reference)              3.03 (2.77 - 3.30)   4.99 (4.30 - 5.79
  Men, OP, n (%)                 3,260 (2.1)                941 (6.3)            279 (11.1)
    Model 3                      1 (reference)              2.75 (2.55 - 2.97)   4.70 (4.12 - 5.37)
  Women, OP, n (%)               1,606 (1.4)                415 (4.2)            102 (8.1)
    Model 3                      1 (reference)              2.81 (2.51 - 3.14)   5.33 (4.31 - 6.59)
  BMI \< 25 kg/m^2^, OP, n (%)   3,187 (1.6)                857 (4.7)            216 (8.4)
    Model 3                      1 (reference)              2.92 (2.70 - 3.16)   5.07 (4.38 - 5.87)
  BMI ≥ 25 kg/m^2^, OP, n (%)    1,679 (2.9)                499 (7.7)            165 (14.0)
    Model 3                      1 (reference)              2.52 (2.27 - 2.80)   4.55 (3.82 - 5.43)

Model 1: unadjusted. Model 2: adjusted for age and sex. Model 3: model 2 plus adjustment for current smoking (versus non-smoking), daily alcohol consumption (versus infrequent/no alcohol consumption), regular exercise (versus no regular exercise), pharmacotherapy (for hypertension, diabetes, or dyslipidemia), body mass index, systolic blood pressure, triglycerides, high-density lipoprotein cholesterol, HbA1c (as continuous variables), and past history of cardiovascular disease (versus no history). TrP: trace proteinuria; T-TrP: transient trace proteinuria; R-TrP: recurrent trace proteinuria; OP: overt proteinuria; AR: automated reading; VR: visual reading. All P values of ORs of T-TrP and R-TrP for OP are \< 0.0001.

Discussion {#s4}
==========

This large epidemiological study showed that TrP, especially R-TrP, was significantly associated with the incidence of OP after 5 years, independently of relevant confounders and the methods detecting TrP. Our results also suggest that the proportion of both types of TrP may be affected to a certain extent by the detection methods for proteinuria. This finding deserves further study to confirm whether the observed difference is due to underestimation by VR or overestimation by AR. The observed relationship of T-TrP and R-TrP against BMI is similar to that of OP \[[@R10]\] and consistent with our previous cross-sectional study \[[@R11]\]. Although this study does not individually demonstrate a transformation from TrP to OP in the time course, the current results strongly suggest that TrP, especially R-TrP, may eventually result in OP. Because measurement of microalbuminuria is time consuming and expensive, TrP may be a surrogate marker for early kidney damage in individuals who are unlikely to have microalbuminuria measured. However, this could increase the false-positive rate for detecting early kidney damage \[[@R06]\]. Therefore, R-TrP may be preferable than T-TrP as a target for intervention because of the reduction in false-positive rate. Consistently, the incident of OP in R-TrP was approximately two times higher compared with that in T-TrP. Clinical studies in recent years \[[@R14]-[@R16]\] have shown that TrP may be a risk factor for metabolic syndrome and increased all-cause mortality. Therefore, not only OP, but also TrP, may have clinical significance for cardiometabolic conditions, including kidney disease.

Some limitations of our study should be mentioned. First, eGFR and measurements related to urine specimens, including urine gravity, hematuria, and bacteriuria, were unavailable in this study. Then, kidney function and the conditions of urine sampling were not considered in this study. However, TrP may be frequently observed in an early stage of kidney disease \[[@R04], [@R07]\]. In addition, it has been shown that GFR is well preserved in patients with microalbuminuria \[[@R17]\]. Therefore, adjustment for eGFR might not largely affect the association between TrP and OP, although this issue deserves further study. Second, although interpretation of AR in dipstick urinalysis may be more sensitive than VR for TrP, similar to OP, this warrants confirmation in additional studies because conflicting results remain \[[@R18]-[@R20]\].

In conclusion, our results suggest that TrP, particularly R-TrP, is substantially associated with the future incidence of OP, which may be independent of confounding factors and the methods detecting TrP. However, further study including eGFR and urine specimens are needed to confirm current results and underlying mechanism.
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